Support: 888-992-3836
Home
NewsWire
Subscriptions
Quotes:
IHub:
Board Search:
All Posts Search:
Member Search:
PM Search:
Login/Register
MAIN MENU
BOARDS
Stocks
Commodities
Forex
Cryptocurrency
The Lounge
CRYPTO
Top Cryptocurrencies
PlusOneCoin Showcase
Top Tokens
New Cryptocurrencies
Crypto Converter
PlusOneCoin Faucet
PlusOneCoin Wallet
PLUS1 Info and Faucet
Top PlusOneCoin Posters
HOT!
Breakout Boards
Most Read
Most Posted
Most Followed Members
Active Boards
New Boards
Site Stats
Poststream
My Stocks Activity
Ticker Buzz Cloud
NEWS
iHub Newswire
Newsletters
All News
Recent News
News By Market
News Scanner
Price & News Alerts
MARKET DATA
Streamer
Level 2
Live Charts
Trades
Portfolio
Toplists
Follow Feed
Trader Alerts
Forex Prices
Commodities
USER TOOLS
Favorites
Mailbox
My Image Gallery
Advanced Search
My Settings
Educational Channel
Upgrade Options
Mailbox
Favorites
Hot!
Breakout Boards
Most Read
Most Posted
Most Followed Members
Active Boards
New Boards
Site Stats
Poststream
My Stocks Activity
Ticker Buzz Cloud
Crypto
Top Cryptocurrencies
PlusOneCoin Showcase
Top Tokens
New Cryptocurrencies
Crypto Converter
PlusOneCoin Faucet
PlusOneCoin Wallet
PLUS1 Info and Faucet
Top PlusOneCoin Posters
Market Data
Streamer
Level 2
Live Charts
Trades
Portfolio
Toplists
Follow Feed
Trader Alerts
Forex Prices
Commodities
Level 2
Home
>
Boards
>
Canadian
>
Medical - Drugs
>
Theralase Technologies Inc. (TSXV:TLT) (TSXV:TLT)
Add TSXV:TLT Price Alert
Hide Sticky
Hide Intro
Jump to Posts Below
Moderators:
Search This Board:
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003+
GO
Created:
06/29/2018 12:36:58 AM
-
Followers:
1
-
Board type:
Free
-
Posts Today:
0
New message board for Theralase Technologies Inc. (TSXV:TLT)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
Detailed Quote
1D
1M
2M
3M
6M
1Y
2Y
3Y
5Y
Post New Msg
My Stocks (0)
View Posters
TSXV:TLT Poststream
Bans (0)
Hide Quote
Filter Disabled
PlusOneCoin Top Posts
Free PlusOneCoin
No plusone'd posts yet. Be the first!
Post
Subject
Go
#13
PR Aug. 22, 2019
frebeach
08/29/2019 12:34:56 PM
#12
PR July 31st, 2019.
frebeach
08/29/2019 12:31:12 PM
#11
Theralase Granted Notice of Acceptance for PhotoDynamic Compounds
frebeach
05/28/2019 11:54:41 AM
#10
Theralase Commences Phase II NMIBC Clinical Study
lonade
04/25/2019 07:32:52 AM
#9
Lightning Strikes Twice: A SECOND Patient Cancer-Free After
lonade
04/09/2019 08:33:43 AM
#6
June 30th, 2018
frebeach
06/29/2018 02:42:00 AM
#1
Test
frebeach
06/29/2018 02:33:47 AM
Post
Subject
Go
Post New Msg
My Stocks (0)
View Posters
TSXV:TLT Poststream
Bans (0)
Hide Quote
Filter Disabled
You must be logged in to give a plus1 award.
Opana® ER Antitrust Trial Concludes With Jury Verdict in Endo's Favor
Micron Technology on Pace for Lowest Close Since November 2020 -- Data Talk
Great Panther Announces 2022 AGM Results
Meta Platforms to End Digital Wallet Novi Pilot on Sept. 1
Intel on Track for Lowest Close Since September 2017 -- Data Talk
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Exela Technologies placed in 2022 Magic Quadrant™ for Finance and Accounting Business Process Outsourcing
Holland America Line Sees a Surge in Demand for Alaska Cruising
Cryptyde, Inc. is Trading on the NASDAQ Capital Market Under the Symbol "TYDE"
Akebia Therapeutics Regaining Rights to Vadadustat in the United States, Europe, China and Access Consortium Countries upon Termination of Collaboration and License Agreements with Otsuka
Accolade Announces Results for Fiscal First Quarter 2023
Terran Orbital Completes NASA Pathfinder Technology Demonstrator 3 Bus Commissioning Less Than One Week After Launch
CTO Realty Growth Announces Second Quarter 2022 Earnings Release and Conference Call Information
Permian Highway Pipeline Announces Final Investment Decision for Expansion Project
Uranium Energy Corp Provides Update on UEX holdings
Talaris Therapeutics Provides FREEDOM-1 Phase 3 Clinical Update
Splash Beverage Group Signs Agreement with Mexcor for Full State Distribution of All Three Beverage Alcohol Brands in Texas
Mullen to Report Strongest Balance Sheet in Company’s History
Jakubowitz Law Reminds Amazon Shareholders of a Lead Plaintiff Deadline of July 5, 2022
Agile Therapeutics Announces Pricing of $24 Million Upsized Public Offering